Taylor Bopp
Overview
Explore the profile of Taylor Bopp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
4
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shi C, Bopp T, Lo H, Tkaczuk K, Lin J
Curr Oncol
. 2024 Oct;
31(10):5737-5751.
PMID: 39451730
Targeting the interleukin-6 (IL-6)/glycoprotein 130 (GP130) signaling pathway holds significant promise for cancer therapy given its essential role in the survival and progression of various cancer types. We have identified...
2.
Lowe A, Rivera Santana M, Bopp T, Quinn K, Johnson J, Ward C, et al.
Front Physiol
. 2024 Mar;
15:1328520.
PMID: 38426207
Muscle reinnervation (MR) surgery offers rehabilitative benefits to amputees by taking severely damaged nerves and providing them with new denervated muscle targets (DMTs). However, the influence of physical changes to...
3.
Nidadavolu L, Cosarderelioglu C, Merino Gomez A, Wu Y, Bopp T, Zhang C, et al.
J Gerontol A Biol Sci Med Sci
. 2023 Jun;
78(10):1740-1752.
PMID: 37310873
Chronic activation of inflammatory pathways (CI) and mitochondrial dysfunction are independently linked to age-related functional decline and early mortality. Interleukin 6 (IL-6) is among the most consistently elevated chronic activation...
4.
Chung T, Bopp T, Ward C, Notarangelo F, Schwarcz R, Westbrook R, et al.
Aging Cell
. 2023 Apr;
22(7):e13849.
PMID: 37078472
Decline in neuromuscular function with aging is known to be a major determinant of disability and all-cause mortality in late life. Despite the importance of the problem, the neurobiology of...